Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 19 of 64 found articles
 
 
  Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis Trial
 
 
Title: Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis Trial
Author: Earl, H.M.
Hiller, L.
Dunn, J.A.
Blenkinsop, C.
Grybowicz, L.
Vallier, A.-L.
Gounaris, I.
Abraham, J.E.
Hughes-Davies, L.
McAdam, K.
Chan, S.
Ahmad, R.
Hickish, T.
Rea, D.
Caldas, C.
Bartlett, J.M.S.
Cameron, D.A.
Provenzano, E.
Thomas, J.
Hayward, R.L.
Appeared in: Annals of oncology
Paging: Volume 28 () nr. 8 pages 1817-1824
Year: 2017
Contents:
Publisher: THE AUTHORS
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 19 of 64 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands